Merus (MRUS) News Today $53.08 -0.22 (-0.41%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$53.12 +0.04 (+0.08%) As of 06/17/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRUS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Net Worth Advisory Group Buys Shares of 5,054 Merus (NASDAQ:MRUS)Net Worth Advisory Group purchased a new position in Merus (NASDAQ:MRUS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 5,054 shares of the biotechnology company's stock, valued at approxJune 14, 2025 | marketbeat.comHarbor Capital Advisors Inc. Has $2.71 Million Stake in Merus (NASDAQ:MRUS)Harbor Capital Advisors Inc. raised its position in shares of Merus (NASDAQ:MRUS - Free Report) by 49.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 64,374 shares of the biotechnology company's stock after acquiring aJune 12, 2025 | marketbeat.comBicara Therapeutics Looks To Reclaim Some Of The Spotlight From MerusJune 11, 2025 | seekingalpha.comMerus’s Strategic Advancements and Promising Trials Justify Buy Rating with $92 Price TargetJune 10, 2025 | tipranks.comUnderappreciated Potential of Merus’s Petosemtamab in Colorectal Cancer: Analyst Highlights Future Opportunities and Financial StabilityJune 9, 2025 | tipranks.comWhy Merus N.V. (MRUS) Crashed On WednesdayJune 5, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,544 Shares of Merus (NASDAQ:MRUS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Merus (NASDAQ:MRUS - Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,744 shares of the biotechnology compaJune 5, 2025 | marketbeat.comBank of America Corp DE Has $1.59 Million Stock Position in Merus (NASDAQ:MRUS)Bank of America Corp DE decreased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 40.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 37,805 shares of the biotechnology company's stock afteJune 5, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Gap Down - What's Next?Merus (NASDAQ:MRUS) Shares Gap Down - Time to Sell?June 4, 2025 | marketbeat.comMerus Shares Slide on Stock OfferingJune 4, 2025 | marketwatch.comMerus N.V. Announces Pricing of $300 Million Public Offering of Common SharesJune 4, 2025 | quiverquant.comMerus N.V. Announces Pricing of Public Offering of Common SharesJune 4, 2025 | globenewswire.comMerus NV Announces Proposed Public Offering of Common Shares | MRUS stock newsJune 3, 2025 | gurufocus.comMerus N.V. Announces Proposed Public Offering of Common SharesJune 3, 2025 | globenewswire.comMerus (NASDAQ:MRUS) Sets New 52-Week High - Should You Buy?Merus (NASDAQ:MRUS) Sets New 12-Month High - Time to Buy?June 3, 2025 | marketbeat.comSquarepoint Ops LLC Buys New Stake in Merus (NASDAQ:MRUS)Squarepoint Ops LLC bought a new stake in Merus (NASDAQ:MRUS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 19,440 shares of the biotechnology company's stock, valued at approximately $817,000. OtherJune 2, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Up 9% - What's Next?Merus (NASDAQ:MRUS) Trading Up 9% - What's Next?May 30, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Down 3.1% - Should You Sell?Merus (NASDAQ:MRUS) Stock Price Down 3.1% - Here's WhyMay 28, 2025 | marketbeat.comPolar Asset Management Partners Inc. Buys Shares of 31,354 Merus (NASDAQ:MRUS)Polar Asset Management Partners Inc. bought a new stake in Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 31,354 shares of the biotechnology company's stock, valued at apprMay 28, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from AnalystsShares of Merus (NASDAQ:MRUS - Get Free Report) have been given a consensus rating of "Buy" by the sixteen analysts that are currently covering the firm, MarketBeat.com reports. Fourteen analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the cMay 28, 2025 | marketbeat.comMerus to Present at Upcoming Investor ConferencesMay 27, 2025 | globenewswire.comMerus (MRUS) Price Target Raised at BMO After Positive Phase 2 DataMay 26, 2025 | finance.yahoo.comNorthern Trust Corp Has $3.21 Million Stake in Merus (NASDAQ:MRUS)Northern Trust Corp increased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 61.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,335 shares of the biotechnology company's stockMay 26, 2025 | marketbeat.comMerus Stock Short Interest Report | NASDAQ:MRUS | BenzingaMay 26, 2025 | benzinga.comBofA Maintains Buy Rating on Merus (MRUS), Lifts PTMay 25, 2025 | insidermonkey.comBofA Maintains Buy Rating on Merus (MRUS), Lifts PTMay 25, 2025 | finance.yahoo.comMerus (NASDAQ:MRUS) Shares Gap Up After Analyst UpgradeMerus (NASDAQ:MRUS) Shares Gap Up on Analyst UpgradeMay 25, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Stock Price Expected to Rise, BMO Capital Markets Analyst SaysBMO Capital Markets lifted their price objective on Merus from $96.00 to $110.00 and gave the company an "outperform" rating in a research report on Friday.May 25, 2025 | marketbeat.comMerus (MRUS) Price Target Raised at BMO After Positive Phase 2 DataMay 25, 2025 | insidermonkey.comMerus (MRUS) Receives a Buy from Truist FinancialMay 25, 2025 | theglobeandmail.comStock Traders Purchase High Volume of Call Options on Merus (NASDAQ:MRUS)Merus (NASDAQ:MRUS - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Traders purchased 5,083 call options on the company. This is an increase of 1,320% compared to the average volume of 358 call options.May 24, 2025 | marketbeat.comTwo Sigma Investments LP Lowers Position in Merus (NASDAQ:MRUS)Two Sigma Investments LP lessened its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 507,741 shares of the biotechnology company's stock after selling 85,298 shares during the period. Two Sigma IMay 24, 2025 | marketbeat.comMerus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCCMay 23, 2025 | finance.yahoo.comMerus Stock Climbs on Positive Trial ResultsMay 23, 2025 | marketwatch.comMerus gains after mid-stage trial data for lead asset in head and neck cancerMay 23, 2025 | msn.comMerus updates on Petosemtamab+Pembrolizumab data in HNSCCMay 23, 2025 | finance.yahoo.comMerus Stock Surges Over 35% On Strong Phase 2 Cancer Trial Results: What's Going On?May 23, 2025 | benzinga.comMerus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s ThrilledMay 23, 2025 | msn.comMRUS: BMO Capital Raises Price Target for Merus to $110 | MRUS Stock NewsMay 23, 2025 | gurufocus.comFrontline, Merus, Intuit And Other Big Stocks Moving Higher On FridayMay 23, 2025 | benzinga.comMerus’ Potential ‘Best-In-Class’ Cancer Treatment Bolsters MRUS Stock 30%May 23, 2025 | tipranks.comPromising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and SafetyMay 23, 2025 | tipranks.comTwo Sigma Advisers LP Has $30.31 Million Holdings in Merus (NASDAQ:MRUS)Two Sigma Advisers LP decreased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 720,800 shares of the biotechnology company's stock after selling 9,000 sharesMay 23, 2025 | marketbeat.comMerus N.V. Reports Positive Interim Clinical Data for Petosemtamab in Combination with Pembrolizumab in Head and Neck CancerMay 22, 2025 | quiverquant.comMerus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCCMay 22, 2025 | globenewswire.comVR Adviser LLC Decreases Position in Merus (NASDAQ:MRUS)VR Adviser LLC lowered its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 34.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 592,411 shares of the biotechnology company's stock after selling 315,552May 22, 2025 | marketbeat.comMerus' (MRUS) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $75.00 price target on shares of Merus in a research report on Monday.May 21, 2025 | marketbeat.comSoleus Capital Management L.P. Sells 86,000 Shares of Merus (NASDAQ:MRUS)Soleus Capital Management L.P. decreased its position in Merus (NASDAQ:MRUS - Free Report) by 21.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 312,321 shares of the biotechnology company's stock after selling 86,000 shares during the periMay 21, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Purchased by Wexford Capital LPWexford Capital LP boosted its position in Merus (NASDAQ:MRUS - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,386 shares of the biotechnology company's stock after purchasingMay 21, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Takes Position in Merus (NASDAQ:MRUS)OMERS ADMINISTRATION Corp bought a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,600 shares of the biotechnology company's stock, valued at approximateMay 21, 2025 | marketbeat.com Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address MRUS Media Mentions By Week MRUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼1.260.90▲Average Medical News Sentiment MRUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼36▲MRUS Articles Average Week Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Today Intra-Cellular Therapies News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Moderna News Today Blueprint Medicines News Today BridgeBio Pharma News Today Roivant Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRUS Stock Free MRUS Stock Alerts